<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 02 Jun 2026 16:12:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  4          ELUTIA INC.               For: Jun 01  Filed by: HighCape Partners GP II, LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+01++Filed+by%3A+HighCape+Partners+GP+II%2C+LLC/26591776.html</link>
   <description>si-local-file:///var/storage/secattach/20260602/26591776.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+01++Filed+by%3A+HighCape+Partners+GP+II%2C+LLC/26591776.html</guid>
   <pubDate>Tue, 02 Jun 2026 16:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	  </item>
  <item>
   <title>Form  4          ELUTIA INC.               For: Jun 01  Filed by: HighCape Partners GP II, LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+01++Filed+by%3A+HighCape+Partners+GP+II%2C+LLC/26591776.html</link>
   <description>si-local-file:///var/storage/secattach/20260602/26591776.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ELUTIA+INC.+++++++++++++++For%3A+Jun+01++Filed+by%3A+HighCape+Partners+GP+II%2C+LLC/26591776.html</guid>
   <pubDate>Tue, 02 Jun 2026 16:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
  <item>
   <title>A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching</title>
   <link>http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Five companies. One overlapping story. The race to rebuild human tissue is moving from the lab into the public markets — fast.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  22, 2026  (GLOBE NEWSWIRE) -- World Street Intelligence News Commentary — There are weeks when the most interesting story on Wall Street isn’t a single ticker. It’s the through-line connecting several of them.&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;The week of May 21, 2026 was one of those weeks. A brand-new Nasdaq listing in regenerative tissue arrived in the middle of a cluster of earnings beats, pipeline launches, and product approvals across a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/A+Reno+Biotech+Just+Rang+the+Nasdaq+Bell+%E2%80%94+Here%E2%80%99s+Why+the+Whole+Regenerative-Medicine+Tape+Is+Worth+Watching/26539474.html</guid>
   <pubDate>Fri, 22 May 2026 10:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.30214420</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ELUT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00168667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00391766</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00493728</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25030674</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31701438</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SSYS</category>
   	  </item>
 </channel>
</rss>
